Join to View Full Profile
Elm and Carlton StBuffalo, NY 14263
Phone+1 716-845-2300
Fax+1 716-845-3519
Dr. Chatta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1995 - 1996- University of WashingtonFellowship, Geriatric Medicine (Internal Medicine), 1988 - 1992
Aurora Health CareResidency, Internal Medicine, 1986 - 1988
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 1985 - 1985
Delhi University College of Medical SciencesClass of 1979
Certifications & Licensure
AK State Medical License 2015 - 2026
NY State Medical License 2016 - 2025
WA State Medical License 1988 - 2025
PA State Medical License 2001 - 2024
AR State Medical License 1997 - 2001
WI State Medical License 1986 - 1989
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer Start of enrollment: 2022 Jan 26
Roles: Principal Investigator, Contact
- Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery Start of enrollment: 2019 Nov 29
Roles: Contact, Principal Investigator
- Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors Start of enrollment: 2019 May 02
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Treatment of advanced urothelial cancer with nivolumab plus chemotherapy versus chemotherapy alone (CheckMate 901 study): a plain language summary.Michiel S van der Heijden, Guru Sonpavde, Thomas Powles, Andrea Necchi, Mauricio Burotto
Future Oncology. 2025-03-01 - A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer.Randy F Sweis, Gurkamal S Chatta, Rohit K Jain, Helen Moon, Scott Edward Delacroix
Clinical Cancer Research. 2025-01-17 - 19 citationsAdjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.Andrea B Apolo, Karla V Ballman, Guru Sonpavde, Stephanie Berg, William Y Kim
The New England Journal of Medicine. 2025-01-02
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
